|
|
Volumn 13, Issue 4, 2012, Pages 421-425
|
|
The effect of peripherally inserted central catheter (PICC) valve technology on catheter occlusion rates--the 'ELeCTRiC' study
a a a a a a |
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
FIBRINOLYTIC AGENT;
UROKINASE;
ADULT;
ADVERSE EFFECTS;
AGED;
CATHETER OBSTRUCTION;
CATHETERIZATION;
CENTRAL VENOUS CATHETER;
CENTRAL VENOUS CATHETERIZATION;
COMPARATIVE STUDY;
CONTROLLED STUDY;
DEVICES;
EARLY TERMINATION OF CLINICAL TRIAL;
EQUIPMENT DESIGN;
FEMALE;
FIBRINOLYTIC THERAPY;
HUMAN;
INTENSIVE CARE UNIT;
MALE;
MIDDLE AGED;
PROCEDURES;
RANDOMIZED CONTROLLED TRIAL;
RISK FACTOR;
TREATMENT OUTCOME;
UNITED KINGDOM;
UPPER EXTREMITY DEEP VEIN THROMBOSIS;
ADULT;
AGED;
CATHETER OBSTRUCTION;
CATHETERIZATION, CENTRAL VENOUS;
CATHETERIZATION, PERIPHERAL;
CENTRAL VENOUS CATHETERS;
EARLY TERMINATION OF CLINICAL TRIALS;
ENGLAND;
EQUIPMENT DESIGN;
FEMALE;
FIBRINOLYTIC AGENTS;
HUMANS;
INTENSIVE CARE UNITS;
MALE;
MIDDLE AGED;
RISK FACTORS;
THROMBOLYTIC THERAPY;
TREATMENT OUTCOME;
UPPER EXTREMITY DEEP VEIN THROMBOSIS;
UROKINASE-TYPE PLASMINOGEN ACTIVATOR;
|
|
EID: 84887250279
PISSN: None
EISSN: 17246032
Source Type: Journal
DOI: 10.5301/jva.5000071 Document Type: Article |
|
Times cited : (26)
|
|
References (0)
|